{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:49:04Z","timestamp":1769165344698,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00417-021-05278-x","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T03:32:21Z","timestamp":1624246341000},"page":"3469-3476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intraocular pressure effect of anti-vascular endothelial growth factor injection for aggressive posterior retinopathy of prematurity"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-8567","authenticated-orcid":false,"given":"Ozdemir","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-8570","authenticated-orcid":false,"given":"Aysegul","family":"Arman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-2262","authenticated-orcid":false,"given":"Cuneyt","family":"Tayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"5278_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/s0022-3476(46)80009-x","volume":"29","author":"TL Terry","year":"1946","unstructured":"Terry TL (1946) Retrolental fibroplasia. J Pediatr 29:770\u2013773. https:\/\/doi.org\/10.1016\/s0022-3476(46)80009-x","journal-title":"J Pediatr"},{"key":"5278_CR2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-381","volume":"142","author":"WM Fierson","year":"2018","unstructured":"Fierson WM, Academy A, of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists, (2018) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 142:e20183061. https:\/\/doi.org\/10.1542\/peds.2018-381","journal-title":"Pediatrics"},{"key":"5278_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/EB.S94436","volume":"8","author":"GE Quinn","year":"2016","unstructured":"Quinn GE (2016) Retinopathy of prematurity blindnesss worldwide: phenotypes in the third epidemic. Eye Brain 8:31\u201336. https:\/\/doi.org\/10.2147\/EB.S94436","journal-title":"Eye Brain"},{"key":"5278_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"Mintz-Hittner, HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group","year":"2011","unstructured":"Mintz-Hittner, HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603\u2013615. https:\/\/doi.org\/10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"5278_CR5","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/IAE.0b013e3181cb6151","volume":"30","author":"KA Drenser","year":"2010","unstructured":"Drenser KA, Trese MT, Capone A Jr (2010) Aggressive posterior retinopathy of prematurity. Retina 30:S37\u2013S40. https:\/\/doi.org\/10.1097\/IAE.0b013e3181cb6151","journal-title":"Retina"},{"issue":"1","key":"5278_CR6","doi-asserted-by":"publisher","first-page":"CD009734","DOI":"10.1002\/14651858.CD009734.pub2","volume":"1","author":"MJ Sankar","year":"2018","unstructured":"Sankar MJ, Sankar J, Chandra P (2018) Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev 1(1):CD009734. https:\/\/doi.org\/10.1002\/14651858.CD009734.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5278_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5935\/0004-2749.20150090","volume":"78","author":"MK Erol","year":"2015","unstructured":"Erol MK, Coban DT, Sari ES, Bilgin AB, Dogan B, Ozdemir O, Tunay ZO (2015) Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity. Arq Bras Oftalmol 78:340\u2013343. https:\/\/doi.org\/10.5935\/0004-2749.20150090","journal-title":"Arq Bras Oftalmol"},{"key":"5278_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10792-016-0257-9","volume":"37","author":"EA Sukgen","year":"2017","unstructured":"Sukgen EA, Gunay M, Kocluk Y (2017) Occurrence of intraocular air bubbles during intravitreal injections for retinopathy of prematurity. Int Ophthalmol 37:215\u2013219. https:\/\/doi.org\/10.1007\/s10792-016-0257-9","journal-title":"Int Ophthalmol"},{"key":"5278_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148019","volume":"11","author":"R Lien","year":"2016","unstructured":"Lien R, Yu MH, Hsu KH, Liao PJ, Chen YP, Lai CC, Wu WC (2016) Neurodevelopmental outcomes of infants with retinopathy of prematurity and bevacizumab treatment. PLoS ONE 11:e0148019. https:\/\/doi.org\/10.1371\/journal.pone.0148019","journal-title":"PLoS ONE"},{"issue":"8","key":"5278_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00417-020-04767-9","volume":"258","author":"M Sacchi","year":"2020","unstructured":"Sacchi M, Lizzio RAU, Villani E, Monsellato G, Lucentini S, Cremonesi E, Luccarelli S, Serafino M, Nucci P (2020) Medical management of pediatric glaucoma: lessons learned from randomized clinical trials. Graefes Arch Clin Exp Ophthalmol 258(8):1579\u20131586. https:\/\/doi.org\/10.1007\/s00417-020-04767-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5278_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991\u2013999. https:\/\/doi.org\/10.1001\/archopht.123.7.991","journal-title":"Arch Ophthalmol"},{"key":"5278_CR12","first-page":"370","volume":"103","author":"R Azad","year":"2005","unstructured":"Azad R, Chandra P (2005) Retinopathy of prematurity. J Indian Med Assoc 103:370\u2013372","journal-title":"J Indian Med Assoc"},{"key":"5278_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.joco.2017.08.007","volume":"30","author":"C Kara","year":"2017","unstructured":"Kara C, Hekimoglu E, Petricli IS, Ak\u0131l H (2017) Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity. J Curr Ophthalmol 30:80\u201384. https:\/\/doi.org\/10.1016\/j.joco.2017.08.007","journal-title":"J Curr Ophthalmol"},{"key":"5278_CR14","first-page":"70","volume":"24","author":"O Ozdemir","year":"2016","unstructured":"Ozdemir O, Ozen Tunay Z, Ozdek S, Erginturk Acar D (2016) The exudative retinal detachment after laser photocoagulation and its treatment in a case of retinopathy of prematurity. Ret-Vit 24:70\u201373","journal-title":"Ret-Vit"},{"key":"5278_CR15","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3928\/01913913-20170531-01","volume":"54","author":"P Chandra","year":"2017","unstructured":"Chandra P, Tewari R, Salunkhe N, Kumawat D, Kumar V (2017) Giant retinal tear with retinal detachment in regressed aggressive posterior retinopathy of prematurity treated by laser. J Pediatr Ophthalmol Strabismus 54:e34\u2013e36. https:\/\/doi.org\/10.3928\/01913913-20170531-01","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"5278_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5336\/ophthal.2015-48256","volume":"26","author":"O Ozdemir","year":"2017","unstructured":"Ozdemir O, Ozen Tunay Z, Erginturk Acar D, Ozmen MC (2017) A case with bilateral anterior segment ischemia, hypotonia and cataract following the treatment for retinopathy of prematurity. Turkiye Klinikleri J Ophthalmol 26:210\u2013214. https:\/\/doi.org\/10.5336\/ophthal.2015-48256","journal-title":"Turkiye Klinikleri J Ophthalmol"},{"key":"5278_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-319-52190-9_6","volume-title":"Retinopathy of prematurity","author":"MJ Shapiro","year":"2017","unstructured":"Shapiro MJ, Blair MP, Gonzalez JMG (2017) Aggressive posterior retinopathy of prematurity (APROP). In: Kychenthal BA, Dorta SP (eds) Retinopathy of prematurity. Springer, Cham, pp 49\u201370"},{"key":"5278_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12886-015-0001-7","volume":"15","author":"MN Menke","year":"2015","unstructured":"Menke MN, Framme C, Nelle M, Berger MR, Sturm V, Wolf S (2015) Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease. BMC Ophthalmol 15:20. https:\/\/doi.org\/10.1186\/s12886-015-0001-7","journal-title":"BMC Ophthalmol"},{"key":"5278_CR19","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2147\/OPTH.S229708","volume":"13","author":"S Obata","year":"2019","unstructured":"Obata S, Higashiyama T, Imamura T, Kakinoki M, Yanagi T, Maruo Y, Ohji M (2019) Short-term changes in intraocular pressure after intravitreal injection of bevacizumab for the treatment of retinopathy of prematurity. Clin Ophthalmol 13:2445\u20132449. https:\/\/doi.org\/10.2147\/OPTH.S229708","journal-title":"Clin Ophthalmol"},{"key":"5278_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10384-019-00661-y","volume":"63","author":"A Kato","year":"2019","unstructured":"Kato A, Okamoto Y, Okamoto F, Saito M, Miyazono Y, Oshika T (2019) Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity. Jpn J Ophthalmol 63:262\u2013268. https:\/\/doi.org\/10.1007\/s10384-019-00661-y","journal-title":"Jpn J Ophthalmol"},{"key":"5278_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","volume":"155","author":"WC Wu","year":"2013","unstructured":"Wu WC, Kuo HK, Yeh PT, Yang CM, Lai CC, Chen SN (2013) An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan. Am J Ophthalmol 155:150-158.e1. https:\/\/doi.org\/10.1016\/j.ajo.2012.06.010","journal-title":"Am J Ophthalmol"},{"key":"5278_CR22","doi-asserted-by":"publisher","first-page":"F170","DOI":"10.1136\/archdischild-2011-301148","volume":"98","author":"BA Darlow","year":"2013","unstructured":"Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE (2013) Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 98:F170\u2013F174. https:\/\/doi.org\/10.1136\/archdischild-2011-301148","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"5278_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/IJG.0b013e31819c4893","volume":"18","author":"M Gismondi","year":"2009","unstructured":"Gismondi M, Salati C, Salvetat ML, Zeppieri M, Brusini P (2009) Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 18:658\u2013661. https:\/\/doi.org\/10.1097\/IJG.0b013e31819c4893","journal-title":"J Glaucoma"},{"key":"5278_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3928\/15428877-20090430-12","volume":"40","author":"MY Kahook","year":"2009","unstructured":"Kahook MY, Kimura AE, Wong LJ, Ammar DA, Maycotte MA, Mandava N (2009) Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging 40:293\u2013295. https:\/\/doi.org\/10.3928\/15428877-20090430-12","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"5278_CR25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.ophtha.2005.10.06","volume":"113","author":"MS Benz","year":"2006","unstructured":"Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN, Carvounis PE (2006) Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113:1174\u20131178. https:\/\/doi.org\/10.1016\/j.ophtha.2005.10.06","journal-title":"Ophthalmology"},{"key":"5278_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10384-012-0194-8","volume":"57","author":"A Cacciamani","year":"2013","unstructured":"Cacciamani A, Oddone F, Parravano M, Scarinci F, Di Nicola M, Lofoco G (2013) Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length. Jpn J Ophthalmol 57:63\u201367. https:\/\/doi.org\/10.1007\/s10384-012-0194-8","journal-title":"Jpn J Ophthalmol"},{"key":"5278_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5005\/jp-journals-10008-1132","volume":"7","author":"G Kampougeris","year":"2013","unstructured":"Kampougeris G, Spyropoulos D, Mitropoulou A (2013) Intraocular pressure rise after anti-vegf treatment: prevalence, possible mechanisms and correlations. J Curr Glaucoma Pract 7:19\u201324. https:\/\/doi.org\/10.5005\/jp-journals-10008-1132","journal-title":"J Curr Glaucoma Pract"},{"key":"5278_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/s0161-6420(90)32637-4","volume":"97","author":"ME Hartnett","year":"1990","unstructured":"Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose T (1990) Anterior segment evaluation of infants with retinopathy of prematurity. Ophthalmology 97:122\u2013130. https:\/\/doi.org\/10.1016\/s0161-6420(90)32637-4","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05278-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05278-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05278-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T06:28:33Z","timestamp":1634538513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05278-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5278"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05278-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ankara City Hospital Ethical Committee (No. E1\/736\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Parents of patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}